These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16833213)

  • 21. Strattera approved to treat ADHD.
    FDA Consum; 2003; 37(2):4. PubMed ID: 12715751
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 23. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 24. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA-Approved Drugs to Treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2019 Mar; 57(3):5-6. PubMed ID: 30835794
    [No Abstract]   [Full Text] [Related]  

  • 26. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
    Eggertson L
    CMAJ; 2005 Mar; 172(7):865. PubMed ID: 15758187
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of methylphenidate in children with ADHD].
    Lauth B
    Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA-Approved Drugs to Treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2017 Mar; 55(3):17-18. PubMed ID: 28287670
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA-Approved Drugs to Treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):13-14. PubMed ID: 29505085
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA-Approved Drugs to Treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2020 Mar; 58(3):5-6. PubMed ID: 32129874
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 34. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate use and divorce.
    Schultz BK
    CMAJ; 2007 Sep; 177(7):751; author reply 751. PubMed ID: 17893352
    [No Abstract]   [Full Text] [Related]  

  • 36. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
    Wigal SB; Wilens TE; Wolraich M; Lerner M
    Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
    Biederman J
    J Clin Psychiatry; 2006; 67 Suppl 8():4-6. PubMed ID: 16961423
    [No Abstract]   [Full Text] [Related]  

  • 39. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC; Cox DJ
    J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
    [No Abstract]   [Full Text] [Related]  

  • 40. Transdermal methylphenidate system: old wine in a new bottle.
    Bukstein OG
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.